Organigram Global (OGI) Competitors $1.96 +0.07 (+3.42%) As of 03:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OGI vs. ACB, CGC, CRON, SNDL, TLRY, VFF, UPB, NBTX, VALN, and PGENShould you be buying Organigram Global stock or one of its competitors? The main competitors of Organigram Global include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Upstream Bio (UPB), Nanobiotix (NBTX), Valneva (VALN), and Precigen (PGEN). Organigram Global vs. Its Competitors Aurora Cannabis Canopy Growth Cronos Group SNDL Tilray Brands Village Farms International Upstream Bio Nanobiotix Valneva Precigen Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Is ACB or OGI more profitable? Organigram Global has a net margin of 2.86% compared to Aurora Cannabis' net margin of -5.66%. Aurora Cannabis' return on equity of -1.49% beat Organigram Global's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-5.66% -1.49% -1.06% Organigram Global 2.86%-8.19%-5.79% Which has higher earnings & valuation, ACB or OGI? Aurora Cannabis has higher revenue and earnings than Organigram Global. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.29$1.63M-$0.19-29.76Organigram Global$117.47M2.25-$33.39M$0.0539.30 Do analysts rate ACB or OGI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.80Organigram Global 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do insiders and institutionals have more ownership in ACB or OGI? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to ACB or OGI? In the previous week, Aurora Cannabis and Aurora Cannabis both had 4 articles in the media. Aurora Cannabis' average media sentiment score of 0.93 beat Organigram Global's score of 0.71 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Organigram Global 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ACB or OGI? Aurora Cannabis has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500. SummaryAurora Cannabis beats Organigram Global on 10 of the 15 factors compared between the two stocks. Get Organigram Global News Delivered to You Automatically Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGI vs. The Competition Export to ExcelMetricOrganigram GlobalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$263.98M$10.28B$6.05B$10.51BDividend YieldN/A1.89%5.73%4.80%P/E Ratio39.3120.4884.9327.30Price / Sales2.2531.96515.79197.96Price / CashN/A25.0637.5761.53Price / Book0.953.4712.426.82Net Income-$33.39M$208.83M$3.32B$276.59M7 Day Performance1.29%-0.53%0.53%0.00%1 Month Performance14.91%3.44%10.24%7.96%1 Year Performance13.58%-4.12%75.92%35.10% Organigram Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGIOrganigram Global1.1751 of 5 stars$1.97+3.4%N/A+7.3%$263.98M$117.47M39.31860ACBAurora Cannabis0.4785 of 5 stars$5.81+2.8%N/A-2.3%$317.65M$357.88M-30.581,130CGCCanopy Growth0.8164 of 5 stars$1.39+1.5%N/A-67.5%$328.59M$225.65M-0.463,150Positive NewsCRONCronos Group1.6761 of 5 stars$2.55-1.2%N/A+15.0%$987.86M$117.61M51.00450SNDLSNDL3.312 of 5 stars$2.56-0.8%$4.50+75.8%+21.4%$677.96M$671.81M-9.482,516TLRYTilray Brands2.3473 of 5 stars$1.58-2.5%$1.94+22.6%+0.6%$1.78B$210.48M-0.682,842Earnings ReportOptions VolumeVFFVillage Farms International1.1617 of 5 stars$3.27+15.1%N/A+248.0%$319.91M$340.18M36.341,400High Trading VolumeUPBUpstream Bio1.991 of 5 stars$18.97+1.8%$56.50+197.8%-14.5%$1.00B$2.37M0.0038News CoverageAnalyst ForecastNBTXNanobiotix1.1999 of 5 stars$22.78+11.1%$11.00-51.7%+480.9%$983.31M$39.18M0.00100Gap DownVALNValneva2.3283 of 5 stars$11.02-3.2%$15.00+36.1%+84.2%$978.71M$183.52M-11.24700PGENPrecigen4.5247 of 5 stars$3.14-3.4%$8.25+162.7%+254.4%$968.41M$3.92M-7.48190 Related Companies and Tools Related Companies ACB Competitors CGC Competitors CRON Competitors SNDL Competitors TLRY Competitors VFF Competitors UPB Competitors NBTX Competitors VALN Competitors PGEN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OGI) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
